Introduction
Diabetic ulcers seem to stall in the inflammatory/proliferative stage of the healing process, allowing infection and inflammation to preclude healing. Antibiotic-resistant bacteria have become a major cause of infections, including diabetic foot infections. Honey that demonstrates a high level of antibacterial activity has been effective against antibiotic-resistant strains of bacteria in laboratory and clinical studies. The potent anti-inflammatory action and antioxidant properties of honey are likely to play an important role in overcoming the impediment to healing that inflammation causes in diabetic ulcers. The action of honey in promoting tissue regeneration through stimulation of angiogenesis and the growth of fibroblasts and epithelial cells, and its insulin-mimetic effect, would also help promote the healing of diabetic ulcers. Honey-impregnated dressings, which hold honey in place on ulcers, help to debride ulcers and to remove the bacterial burden to help promote good healing rates with neuropathic ulcers. In ischemic ulcers that cannot heal because of lack of tissue viability, these honey dressings keep the ulcers clean and prevent infection.
In an article by Sweitzer et al, 1 the authors present a comprehensive review of the reasons why diabetic wounds do not heal and provide data on the magnitude of the problem this causes. They note that many of the nearly 2 million cases of chronic diabetic foot ulcers in the United States ultimately result in amputation, with a 2-year survival rate after these amputations of only 50% to 60%. They also discuss the need for new, smart matrix therapies and how the development of these will require a multidisciplinary translational research approach.
Research on tissue-engineered skin substitutes began approximately 20 years ago; however, this form of therapy is not widely used in standard clinical practice. Thus, the authors believe there is an immediate need for an effective therapy for chronic diabetic ulcers. This article will propose that the modern development of an ancient and traditional treatment for woundsVdressing them with honeyVprovides a solution to the problem of advancing diabetic ulcers from a stalled state of healing.
Historical Usage of Honey
The ancient Egyptians, Assyrians, Chinese, Greeks, and Romans all used honey, alone and in combination with herbs, to treat wounds. 2 Aristotle (circa 350 BC) wrote of honey being a salve for wounds and sore eyes, 3 and Dioscorides (circa 50 AD) wrote of honey being ''good for sunburn and spots on the face'' and ''for all rotten and hollow ulcers.'' 4 The usage of honey has continued into present-day folk medicine; for example, it is a traditional therapy for infected leg ulcers in Ghana. 5 In recent times, it has been rediscovered by the medical profession, 2 possibly because the ''antibiotic era'' is coming to an end as increasing numbers of bacterial strains develop resistance to antibiotics. 6 
Modern Clinical Evidence
The clinical evidence in support of the effectiveness of honey in wound care has been comprehensively reviewed. 7 This review summarizes the findings of 17 randomized controlled trials involving 1965 participants and 5 clinical trials of other forms involving 97 participants treated with honey. The trials found that honey was more effective than the control treatments, which were mostly conventional woundcare practices. Only in 1 trial, on burns, was the control treatment, early surgical tangential incision, found to be more effective than dressing the wounds with honey; this was only in respect of control of infection. The review also summarizes the findings of 16 trials on 533 wounds on experimental animals; again, honey was found to be more effective than the controls in assisting wound healing. In addition, a large amount of evidence is summarized in the form of case studies that have been reported. Ten publications have reported on multiple cases, totaling 276 cases. There are also 35 reports of single cases. 7 The authors believe this evidence is far greater than that for modern wound dressings. The promotional efforts for modern wound dressings, compared with the marketing of honey, may give clinicians the impression that modern dressings offer much more evidence than honey. In fact, the authors suggest that only poor-quality trials exist to support the modern wound dressings used today. 8 Perhaps the most heavily marketed wound dressings are the nanocrystalline silver dressings. Yet, if the PubMed database is searched for clinical evidence to support their use, it is observed that only a small amount of significant evidence has been published to date. A conclusion reached in a recent systematic review of publications on the use of advanced dressings (hydrocolloids, polyurethane, alginate, dextranomer, polyhydroxyethyl methacrylate, amino acid copolymer, etc) in the treatment of pressure ulcers found that their generalized use in the treatment of pressure ulcers is not supported by quality research evidence. 9 At present, a general movement toward evidence-based medicine exists. Following this approach, decisions should be made based on the available evidence. If randomized controlled trials of the highest quality have not been conducted, then it is necessary to consider evidence of a lower quality. It is the authors' opinion that marketing campaigns should not influence clinical decisions without good clinical evidence.
Usage of Honey on Diabetic Ulcers
Although there is a vast amount of literature reporting the effectiveness of honey in healing wounds, few articles have been published specifically on the treatment of diabetic foot ulcers with honey. Seven clinical trials, with a total of 255 participants, have been conducted using honey on chronic wounds, with positive results for honey being reported from all of these. 7 In addition, more than 100 case reports have demonstrated honey as being more effective than conventional treatment for chronic wounds. 7 Diabetic ulcers were included in 1 report in the list of recalcitrant wounds and ulcers of varied etiology that ''showed remarkable improvement'' when treated with honey. These were all wounds showing no signs of healing or were increasing in size, after 1 to 24 months of treatment with chlorinated lime and boric acid, acriflavine, framycetin, or neomycin sulfate and bacitracin zinc. 10 In a brief report on using honey to treat septic wounds, chronic ulcers, burns, and pyogenic abscesses, 6 patients had diabetesV5 with a septic foot and 1 with an abscess in the thigh. 11 Healing time was 7, 10, 14, and 30 days, respectively, for 4 of the foot wounds and 15 days for the abscess, and there was no improvement after 56 days for a foot wound on 1 patient who was ill.
Another report, on a single case, was on treatment of diabetic foot ulcers, 8 Â 5 and 3 Â 3 cm, on a 79-year-old patient. 12 The ulcers remained unhealed after 14 months of treatment with an orthotic device, antibiotics, topical therapies by a wound care expert, and 4 surgeries. Methicillinresistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Pseudomonas were present in wound tissue. After initiating treatment with honey, the ulcers were granulating within 2 weeks and were healed within 6 and 12 months. Two years later, the ulcers had not recurred. Although honey contributed to healing the ulcers after nothing else had worked, the healing was still slow. This may be because commercially sold honey was used, which is honey that is usually processed in a way that destroys most of the antibacterial activity and possibly removes other beneficial components. In the other 2 reports, unprocessed honey was used, thus allowing its therapeutic properties to remain intact.
Antibacterial Activity of Honey
A number of published laboratory studies have shown that honey has broad-spectrum antibacterial activity. 13 However, most of these studies do not consider that honeys can vary as much as 100-fold in the potency of their antibacterial activity. 14 Only in the more recently published studies was the testing of the sensitivity of various species of bacteria to honey done using honeys selected to have antibacterial potency near the median level found in surveys of large numbers of samples. Laboratory studies with active Manuka (Leptospermum scoparium) honey with antibacterial potency near the median level have shown the minimum inhibitory concentration (MIC [ie, the concentration down to which honey could be diluted by wound exudate and still prevent bacterial growth]) to be 2% to 3% for S aureus, 15 3.3% to 4% for coagulase-negative staphylococci, 16 5.5% to 9% for Pseudomonas, 17,18 2.7% to 3% for MRSA, 19 and 3.8% to 5% for VRE. 19 The antibacterial potency of the honeys used in the various honey wound-care products now on sale manufactured from Leptospermum honey (Manuka honey and Jellybush honey) is higher than that of the honey used in these studies, but there are other wound-care products manufactured from honeys not selected to have high levels of antibacterial activity. 20 Another consideration is the type of antibacterial activity in honey. Most honeys owe their antibacterial activity (beyond that just due to the osmotic effect of the high sugar content) to the production of hydrogen peroxide by an enzyme that the bees secrete into the nectar harvested to make honey. 13 But some Manuka and Jellybush honeys also have a high activity due to a phytochemical antibacterial component that comes from the nectar of some varieties of Leptospermum (L scoparium, Leptospermum polygalifolium, and possibly others). Although in laboratory testing the MIC values recorded are near the same for mid-range honeys of either type, this would not be the case on a wound. The enzyme catalase, which rapidly breaks down hydrogen peroxide, is in wound fluid and in cells in wound tissues; thus, honeys other than the Leptospermum ones would have their antibacterial activity greatly decreased. In addition, all types of honey vary from batch to batch in their antibacterial potency. Much of the Manuka and Jellybush honey sold commercially has little or none of the phytochemical antibacterial component, but the Leptospermum honey sold for medical use has standardized high levels of it.
Why Does Honey Work on Diabetic Ulcers?
Infection of a wound impairs its healing, and the toxins produced by bacteria can stop the growth of cells that repair the wound. Bacterial proteases can digest away the matrix necessary for tissue replacement and digest cell growth factors. Components of the outer coat of the bacteria can stimulate a strong inflammatory response, and the resultant inflammation then prevents healing and, if severe, can activate proteases to cause ulceration.
Foot infections are a serious complication of diabetes and a leading cause of diabetes-related hospitalizations. Unfortunately, amputation may be unavoidable when infections fail to respond to therapy.
The development of bacteria that are resistant to antibiotics has become a major global problem. MRSA has become a major cause of infections, including diabetic foot infections. Initially, it was associated only with hospitalacquired infections but now is also a problem in the community. The effectiveness of honey in clinical usage in clearing infection with MRSA 12,21-24 and VRE 12 has been reported. In addition to its antibacterial action, honey has been reported to have a rapid debriding effect, which painlessly lifts off slough and necrotic tissue, making surgical debridement unnecessary. 25 Diabetic ulcers, instead of going through the normal 4 overlapping stages of healingVhemostasis, inflammation, proliferation, and remodellingVseem to be arrested in the inflammatory/proliferative process. 1 The anti-inflammatory action of honey was noted by Dioscorides 2 millennia ago, who wrote of honey used as a treatment for sunburn. 4 Since then, a large amount of clinical and histological evidence has been gathered on the anti-inflammatory action of honey, which has been reviewed. 26 The anti-inflammatory action of honey would decrease the excessive activity of collagenase and elastase, a feature of inflammatory conditions that causes the premature degradation of collagen and growth factors in chronic wounds. 1 A characteristic of the extracellular matrix in wounds in diabetes is the presence of advanced glycation and lipoxidation end products that stimulate oxidative stress and inflammation in wounds. 1 The antioxidant properties of honey would be beneficial in counteracting these effects. Another advantage of using active Manuka honey, rather than other types of honey, is that it does not generate hydroxide free radicals like honey with antibacterial activity due to hydrogen peroxide does, and rapidly quenches any formed by the Fenton reaction. 27 The slow healing rates seen in diabetic wounds could be due to a lack of insulin or lack of responsiveness to insulin. Insulin both regulates the uptake of glucose into cells and functions as a growth hormone, and intravenous infusion or topical application of insulin improves the rate of wound healing. [28] [29] [30] Honey has an insulin-mimetic effect: When administered by inhalation as an aerosol, honey significantly reduced random blood glucose (measured 30 minutes after inhalation) and significantly reduced the fasting blood glucose level (3 hours after inhalation), and the intensity of hyperglycemia was significantly lowered in the glucose tolerance test after honey inhalation. 31 
Modern Developments
In the ''rediscovery'' of the use of honey for wound care, there has been a lack of awareness of some ancient wisdom. Four millennia ago, the ancient Egyptians mixed cotton fibers and fat into honey to create a dressing that would hold the honey on a wound. 32 It is necessary to create a retentive dressing of some sort, because honey liquefies at body temperature and flows off a wound. It takes very little dilution of honey with wound exudate to make the honey watery. The water content of honey is bound up on sugar molecules, so it does not easily wet absorbent dressing materials. For example, if honey is applied directly to a wound or via an absorbent dressing, the honey tends to be squeezed out laterally when the dressing is held on the wound. The honey needs to be soaked into an absorbent dressing before it is applied to the wound, so it retains its composition. A variety of honey-impregnated dressings are now available as sterile medical products. 20 In the authors' initial work on the clinical use of honey dressings, a Gamgee type of dressing (a pad of cellulose fibers enclosed in a gauze bag) impregnated with honey was used. It was determined that it was necessary to change the dressing up to 3 times a day in heavily exuding wounds, as the exudate flushed the honey from the side of the dressing facing the wound to the outside of the dressing pad or even right through it and into the secondary dressing. This left no honey in contact with the wound bed, thus healing was slowed, adhesion of the dressings occurred, and maceration of skin around the wound developed. This situation was greatly improved by using a honey-impregnated alginate fiber dressing pad, as the alginate fibers transform to a gel when wound exudate is absorbed into them. Therefore, the honey is held in a soft gel in contact with the wound bed rather than being flushed into the secondary dressing, so less frequent changes of dressings are needed. By keeping sufficient honey in contact with the wound bed through changing the dressings frequently enough to cope with the level of exudate, the level of exudate will decrease because of the anti-inflammatory activity of honey. However, if dressings are not changed frequently enough and the honey is washed away, then the anti-inflammatory activity will also be washed away and the wound will remain highly exudative.
Another type of dressing combines honey with sodium alginate to gel it, giving a rubbery material that swells as it absorbs exudate. 33 This has a massive capacity to absorb exudate without the honey being flushed from the wound bed. This style of dressing is expected to be available for clinical evaluation soon.
Conclusions
By updating the ancient wisdom of using a honey selected as the best for medical use (the authors use active Manuka honey with a high level of the nonperoxide antibacterial activity that is unique to Leptospermum honey, processed with minimal heating to avoid damaging its therapeutic properties) and creating a dressing material to hold the honey in place on the wound (alginate dressing pads impregnated with this honey), the authors have seen positive results in the healing of diabetic ulcers. Honey dressings were also used on neuropathic foot ulcers where, despite pressure offloading, healing was inhibited by the presence of Pseudomonas and S aureus. These dressings were used to debride the ulcers and reduce the bacterial burden, promoting improved healing rates. With ischemic foot ulcers, honey dressings were used to prevent infection while waiting for revascularization to occur.
The authors conclude that honey is particularly useful for diabetic ulcers that are otherwise difficult to debride, particularly where bacterial loading may be a confounding factor in the creation of slough. &
